McCrystal M., Anderson N.E., Jones R.W., Evans B.D.
Department of Clinical Oncology, Auckland Hospital; Neurology Department, Auckland Hospital; and National Women's Hospital and Greenlane Hospital, Auckland, New Zealand.
Int J Gynecol Cancer. 1995 Sep;5(5):396-399. doi: 10.1046/j.1525-1438.1995.05050396.x.
A 54-year-old female with small volume residual stage III ovarian cancer had received two courses of carboplatin chemotherapy with obvious response, when she developed rapidly progressive neurological symptoms. Over a period of 48 h, an incapacitating syndrome of ataxia, nystagmus and dysarthria evolved. Central nervous system metastases were excluded by computed tomography scanning and cerebrospinal fluid cytology. Anti-Purkinje cell antibodies ('anti-Yo') detected in the serum confirmed the diagnosis of paraneoplastic cerebellar degeneration. Isolated reports have suggested that the clinical course of this condition can be ameliorated with high dose steroids and plasmapheresis. However, in this case the very early introduction of both these did not bring about any improvement in the patient's symptoms. She remained severely incapacitated and unable to care for herself for the remaining 15 months of her life. The patient died of progressive ovarian cancer that had become clinically evident 10 months after the onset of neurological symptoms. This case illustrates many of the classical features of this rare condition, and the world literature is reviewed.
一名54岁患有少量残留Ⅲ期卵巢癌的女性接受了两疗程卡铂化疗,反应明显,随后出现快速进展的神经症状。在48小时内,出现了共济失调、眼球震颤和构音障碍的失能综合征。计算机断层扫描和脑脊液细胞学检查排除了中枢神经系统转移。血清中检测到的抗浦肯野细胞抗体(“抗Yo”)确诊为副肿瘤性小脑变性。个别报告表明,高剂量类固醇和血浆置换可改善这种疾病的临床病程。然而,在本例中,这两种治疗方法的早期应用均未使患者症状得到任何改善。在其生命的剩余15个月里,她一直严重失能,无法自理。患者死于神经症状出现10个月后临床上明显的进展性卵巢癌。本病例说明了这种罕见疾病的许多典型特征,并对世界文献进行了综述。